Xilio Development
Price & Volume
Stats
See more52W Range | $0.61-$1.70 |
Market Cap | $41.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $15M |
Revenue Growth (YoY) | 243% |
Gross Profit (12 Mos) | $13M |
Diluted EPS | -$0.70 |
News
See moreYahoo Finance • 2 months ago
Xilio Development earnings missed by $0.06, revenue topped estimates
Yahoo Finance • 2 months ago
Xilio Therapeutics GAAP EPS of -$0.16 misses by $0.06
Yahoo Finance • 2 months ago
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
Yahoo Finance • 2 months ago
Bristol Myers Squibb and Bain Capital Form New Immunology Company
About
CEO | Dr. Rene Russo BCPS, Pharm.D. |
CFO | Mr. Christopher Frankenfield |
Address | 828 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 64 |
